Location History:
- Yashiro, JP (1987)
- Katoh, JP (1991 - 1992)
- Hyogo, JP (1987 - 2001)
- Katoh-gun, JP (1997 - 2001)
- Osaka, JP (2002 - 2017)
Company Filing History:
Years Active: 1987-2017
Title: Kazuharu Ienaga: Pioneering Innovations in Chronic Kidney Disease Treatment
Introduction
Kazuharu Ienaga, based in Hyogo, Japan, is an accomplished inventor recognized for his significant contributions in the medical field, particularly in the treatment of chronic kidney disease. With an impressive portfolio of 15 patents, Ienaga continues to advance healthcare solutions that enhance patient outcomes.
Latest Patents
Among his latest innovations are two notable pharmaceutical agents aimed at combating chronic kidney disease. The first is a progress-suppressing or improving agent designed to provide relief to patients experiencing rapid declines in renal function. This agent incorporates 5-hydroxy-1-methylhydantoin as its active ingredient, demonstrating considerable efficacy in managing the progressive symptoms of kidney deterioration. Clinical evidence suggests that this pharmaceutical agent is both highly safe and effective, filling a critical gap for safe therapeutic options for rapidly progressive chronic kidney disease.
The second patent focuses on an agent for hypoalbuminaemia, intricately linked to the management of kidney-related health conditions. Together, these inventions underscore Ienaga's commitment to innovating solutions for pressing medical challenges.
Career Highlights
Kazuharu Ienaga works at Nippon Zoki Pharmaceutical Co., Ltd, a prominent company in the pharmaceutical sector, where he has made significant strides in drug development and research. Through his role, he has influenced both clinical practices and pharmaceutical advancements, showcasing a dedication to improving patient care through innovative approaches.
Collaborations
Ienaga's work has been enhanced through collaborations with notable colleagues such as Ko Nakamura and Kunihiko Higashiura. Together, they have explored various aspects of pharmaceutical research, sharing insights that lead to groundbreaking discoveries, further strengthening the impact of their innovations in the medical field.
Conclusion
As a prolific inventor, Kazuharu Ienaga stands at the forefront of medical innovation, particularly in the realm of chronic kidney disease. His latest patents not only demonstrate his ingenuity but also reflect his commitment to enhancing the quality of life for patients. With continued collaboration and research, Ienaga is poised to make even greater contributions to medicine, solidifying his legacy as a key figure in pharmaceutical advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.